LPCN logo
LPCN NASDAQ US

Lipocine Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Mar 2014
$2.05
▼ $-7.20 (-77.84%)
Vol 7.3M
3
Quality Score
fail
Mkt Cap
$44.6M
ROE
-30.6%
Margin
-126.7%
D/E
0.00
Beta
1.11
52W
$3–$6

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Similar Stocks

VYNE
Vyne Therapeutics Inc
$19.3M
CTXR
Citius Pharmaceuticals Inc
$16.1M
HIND
Vyome Holdings Inc
$19.4M
CURX
Curanex Pharmaceuticals Inc
$9.4M
TRAW
Traws Pharma Inc
$9.0M
JUNS
Jupiter Neurosciences Inc
$35.1M
BFRI
Biofrontera Inc
$6.6M
CVKD
Cadrenal Therapeutics Inc
$15.9M

Earnings

Beat rate: 50.0%
Next Report May 06, 2026
EPS Estimate: $-0.54
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.54 — —
Dec 2025 $-0.62 $-0.42 +$0.20
Sep 2025 $-0.55 $-0.59 $-0.04
Jun 2025 $-0.41 $-0.41 $0.00

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -23.6% -23.6% -23.7% -23.7% -23.6% -30.6%
P/E (TTM) — — — — — —
Net Margin -354.1% -54.4% -54.4% -54.4% -54.4% -126.7%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 12.71 12.71 12.41 12.41 12.71 8.25

Key Ratios

ROA (TTM)
-28.2%
P/S (TTM)
10.31
P/B
1.2
EPS (TTM)
$-1.04
CF/Share
$-3.09
Rev Growth 3Y
-11.5%
52W High
$5.50
52W Low
$2.52
$2.52 52-Week Range $5.50

How does LPCN compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

LPCN AARD ACB ACRS ADIL

LPCN valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
10.3
▲ 108% above peers (5.0)
vs Peers
vs Industry
Pricier
P/B ratio
1.2
▼ 41% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

LPCN profitability vs Pharmaceuticals peers

ROE
-30.6%
▲ 44% above peers (-54.3%)
vs Peers
vs Industry
Below avg
Net margin
-126.7%
▼ 167% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-28.2%
▲ 25% above peers (-37.4%)
vs Peers
vs Industry
Below avg

LPCN financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
8.3
▲ 146% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.1
▲ 19% above peers (0.9)
vs Peers
vs Industry
More volatile

LPCN fundamentals radar

LPCN Peer median Industry

LPCN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

LPCN vs peers: key metrics

Latest News

No related news yet